156 related articles for article (PubMed ID: 169487)
1. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
Waldmeier P; Hedwal PR; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
Henning M
J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
[No Abstract] [Full Text] [Related]
3. Acute and chronic administration of alpha-methyldopa: regional levels of endogenous and alpha-methylated catecholamines in rat brain.
Conway EL; Louis WJ; Jarrott B
Eur J Pharmacol; 1978 Dec; 52(3-4):271-80. PubMed ID: 729639
[TBL] [Abstract][Full Text] [Related]
4. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
DAY MD; RAND MJ
Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
[TBL] [Abstract][Full Text] [Related]
5. Studies on the hypotensive action of alpha-methyldopamine.
Finch L; Hersom A; Hicks P
Br J Pharmacol; 1975 Aug; 54(4):445-51. PubMed ID: 1100157
[TBL] [Abstract][Full Text] [Related]
6. Adrenaline depletion in the hypothalamus of the rat after chronic alpha-methyldopa.
Beart PM; Prosser D; Louis WJ
Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):25-31. PubMed ID: 7471519
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
Henning M; Rubenson A
J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
[No Abstract] [Full Text] [Related]
8. Centrally induced hypotension by alpha-methyldopa and alpha-methylnoradrenaline in normotensive and renal hypertensive rats.
Nijkamp FP; De Jong W
Prog Brain Res; 1977; 47():349-68. PubMed ID: 337354
[No Abstract] [Full Text] [Related]
9. Antihypertensive metabolites of alpha-methyldopa.
Robertson D; Tung CS; Goldberg MR; Hollister AS; Gerkens JF; Oates JA
Hypertension; 1984; 6(5 Pt 2):II45-50. PubMed ID: 6094349
[TBL] [Abstract][Full Text] [Related]
10. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
Henning M
Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
[No Abstract] [Full Text] [Related]
11. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
Thoenen H; Haefely W; Gey KF; Hürlmann A
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
[No Abstract] [Full Text] [Related]
12. Correlation between fall in blood pressure and in vivo amine release after alpha-methylDOPA.
Kapoor V; Chalmers J
Eur J Pharmacol; 1989 May; 164(3):531-8. PubMed ID: 2767124
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of carbidopa to alpha-methyldopamine and alpha-methylnorepinephrine in rats.
Shelton RC; Karoum F; Chuang LW; Wyatt RJ
Biochem Pharmacol; 1985 Oct; 34(20):3623-6. PubMed ID: 3902027
[TBL] [Abstract][Full Text] [Related]
14. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
Louis WJ; Conway E; Summers R; Beart P; Jarrott B
Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
[TBL] [Abstract][Full Text] [Related]
15. alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase.
Mwaluko G; Weinshilboum R
Br J Clin Pharmacol; 1982 Aug; 14(2):231-9. PubMed ID: 7049213
[TBL] [Abstract][Full Text] [Related]
16. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
Uretsky NJ; Seiden LS
J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
[No Abstract] [Full Text] [Related]
17. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats.
Rankin GO; Watkins BE; Sawutz DG
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417
[TBL] [Abstract][Full Text] [Related]
18. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-methylnoradrenaline and alpha-methyldopamine in reserpine-induced ulcers in rats.
Sandor V; Cuparencu B
Pharmacology; 1981; 23(2):91-4. PubMed ID: 7031706
[TBL] [Abstract][Full Text] [Related]
20. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats.
Freed CR; Wang CH; U'Prichard DC
Hypertension; 1984; 6(5 Pt 2):II34-9. PubMed ID: 6094347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
